Immunome Inc. Gains 19.46%
Mon, Jan 24, 2022 at 05:30 PM
Immunome Inc. (IMNM:NASDAQ) jumped higher at $9.27, representing a gain of 19.5%. On Fri, Jan 21, 2022, IMNM:NASDAQ hit a New 2-Week Low of $7.76. The stock appeared on our News Catalysts scanner on Tue, Jan 11, 2022 at 01:12 PM in the 'BIOTECH' category. From Mon, Jan 10, 2022, the stock recorded 25.00% Up Days and 22.22% Green Days
About Immunome Inc. (IMNM:NASDAQ)
Immunome Inc is a biopharmaceutical company engaged in the discovery and development of novel antibody-based drugs.
Top 10 Gainers:
- Exterran Corporation (EXTN:NYSE), 59.67%
- ShiftPixy, Inc. (PIXY:NASDAQ), 38.71%
- Kohl's Corporation (KSS:NYSE), 36.02%
- Greenwich LifeSciences Inc (GLSI:NASDAQ), 26.99%
- Sweetgreen Inc. Class A (SG:NYSE), 23.34%
- Gelesis Holdings Inc. (GLS:NYSE), 22.37%
- Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ), 21.25%
- Atlas Technical Consultants, Inc. (ATCX:NASDAQ), 20.13%
- Immunome Inc. (IMNM:NASDAQ), 19.46%
- Akouos Inc. (AKUS:NASDAQ), 19.14%